Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome

Archives of Dermatology

Volumn 141, Issue 7, 2005, Pages 873-878

  Kawakami, Tamihiro ^a   Soma, Yoshinao ^a   Kawasaki, Kanade ^a   Kawase, Ayumi ^a   Mizoguchi, Masako ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PRANLUKAST;

ADULT; AGED; ASTHMA; BIOPSY; CELL INFILTRATION; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; DERMIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHILIA; FEMALE; GRANULOMA; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEG; LEUKOCYTOCLASTIC VASCULITIS; MALE; MONONEUROPATHY MULTIPLEX; NERVE FIBER; PAIN; PARESTHESIA; PETECHIA; PRIORITY JOURNAL; PURPURA; RETROSPECTIVE STUDY; REVIEW; SKIN DEFECT;

ADULT; AGED; BIOPSY, NEEDLE; CHURG-STRAUSS SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONONEUROPATHIES; PREDNISOLONE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 23044509874     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.7.873     Document Type: Review

References (28)

1. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63:65-81.
2. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore). 1996;75:17-28.
3. Davis MD, Daoud MS, McEvoy MT, Su WP. Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation. J Am Acad Dermatol. 1997;37:199-203.
4. Gibson LE. Granulomatous vasculitides and the skin. Dermatol Clin. 1990;8:335-345.
5. Crotty CP, DeRemee RA, Winkelmann RK. Cutaneous clinicopathologic correlation of allergic granulomatosis. J Am Acad Dermatol. 1981;5:571-581.
6. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951;27:277-301.
7. Tlacuilo-Parra A, Soto-Ortiz JA, Guevara-Gutierrez E. Churg-Strauss syndrome manifested by urticarial plaques. Int J Dermatol. 2003;42:386-388.
8. Sangueza OP, Caudell MD, Mengesha YM, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol. 2002;47:251-257.
9. Drage LA, Davis MD, De Castro F, et al. Evidence for pathogenic involvement of eosinophils and neutrophils in Churg-Strauss syndrome. J Am Acad Dermatol.2002;47:209-216.
10. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-1100.
11. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.
12. Csernok E, Gross WL. Primary vasculitides and vasculitis confined to skin: clinical features and new pathogenic aspects. Arch Dermatol Res. 2000;292:427-436.
13. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41:1521-1537.
14. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42:421-430.
15. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis: EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53:743-753.
16. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003;361:587-594.
17. Sorensen SF, Slot O, Tvede N, Petersen J. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis. 2000;59:478-482.
18. Reid AJ, Harrison BD, Watts RA, et al. Churg-Strauss syndrome in a district hospital. QJM. 1998;91:219-229.
19. Hunder GG. The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med. 1998;129:417-418.
20. Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med. 1998;129:345-352.
21. Costello RW, Schofield BH, Kephart GM, Gleich GJ, Jacoby DB, Fryer AD. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am J Physiol. 1997;273:L93-L103.
22. Guillevin L, Visser H, Noel LH, et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome - 62 patients. J Rheumatol. 1993;20:1345-1349.
23. Solans R, Bosch JA, Perez-Bocanegra C, et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford). 2001;40:763-771.
24. Tervaert JW, Kallenberg CG. Anti-myeloperoxidase antibodies in Churg-Strauss syndrome. J Neurol. 1993;240:449-450.
25. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA. 1998;279:455-457.
26. Franco J, Artes MJ. Pulmonary eosinophilia associated with montelukast. Thorax. 1999;54:558-560.
27. Wechsler ME, Finn D, Gunawardena D, et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest. 2000;117:708-713.
28. Kinoshita M, Shiraishi T, Koga T, et al. Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol. 1999;103:534-535.